The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of cytotoxic agents after progression of anti-PD-(L)1 antibody for pretreated metastatic gastric cancer.
 
Kyoko Kato
No Relationships to Disclose
 
Yukiya Narita
Honoraria - Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
 
Seiichiro Mitani
Honoraria - Merck Serono
 
Kazunori Honda
No Relationships to Disclose
 
Toshiki Masuishi
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hiroya Taniguchi
Honoraria - Bayer; Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Boehringer Ingelheim (Inst); MSD Oncology (Inst); Otsuka (Inst); Takeda (Inst)
 
Shigenori Kadowaki
No Relationships to Disclose
 
Takashi Ura
No Relationships to Disclose
 
Masashi Ando
No Relationships to Disclose
 
Masahiro Tajika
Speakers' Bureau - Ajinomoto
Research Funding - Ajinomoto (Inst)
 
Kei Muro
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha